Hana Weissman
哈娜·魏斯曼
PhD
Senior Vice President, Research研究高级副总裁
👥Biography 个人简介
Industry leader in allogeneic CAR-T cell development. Key figure in advancing ALLO-501 and PBCAR0191 programs, pioneering off-the-shelf T-cell therapy platforms that eliminate donor dependency and enable scalable manufacturing for large patient populations.
🧪Research Fields 研究领域
🎓Key Contributions 主要贡献
Allogeneic CAR-T Platform
Drove development of ALLO-501 and PBCAR0191 allogeneic CD19-targeted CAR-T programs through IND and into clinical trials, establishing a foundation for scalable off-the-shelf cell therapies.
Representative Works 代表性著作
Allogeneic CAR T cells: more than ease of access?
Drugs (2021)
Comprehensive review of allogeneic CAR-T platforms addressing manufacturing, immunogenicity, and clinical translation challenges.
🏆Awards & Recognition 奖项与荣誉
📄Data Sources 数据来源
Last updated: 2026-01-15 | All information from publicly available academic sources
Related Experts 相关专家
Carl H. June
University of Pennsylvania
Michel Sadelain
Memorial Sloan Kettering Cancer Center
Crystal L. Mackall
Stanford University
Katy Rezvani
MD Anderson Cancer Center
关注 哈娜·魏斯曼 的研究动态
Follow Hana Weissman's research updates
留下邮箱，当我们发布与 Hana Weissman（Allogene Therapeutics）相关的新研究或访谈时，我们会通知你。
Explore More Experts
Discover the researchers shaping the future of cancer treatment